September 9, 2003Circulation

Reoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment

View Full Paper

Ask AI

Bookmark

Authors

WJW.R. Eric JamiesonDartmouth College LBLawrence H. BurrVancouver Coastal Health RMRobert T. MiyagishimaVancouver Coastal Health

Discussion

Member takes

Implication

Elective reoperation before NYHA IV or emergent status may lower mortality after mitral bioprosthetic failure; leaves open optimal timing strategies in contemporary practice.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jamieson et al. (2003) studied this question.

synapsesocial.com/papers/6a7ca3b2d0b007fc43cf7f38 https://doi.org/10.1161/01.cir.0000089184.46999.f4

View Full Paper

Ask AI

Bookmark

Implication

Elective reoperation before NYHA IV or emergent status may lower mortality after mitral bioprosthetic failure; leaves open optimal timing strategies in contemporary practice.

Reoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment

Discussion

Member takes

Implication

Key Points

Cite This Study

Reoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider